AerCap Holdings N.V., the world's largest aircraft lessor, is drawing renewed attention from value investors. Despite geopolitical headwinds and a cyclical reputation, its robust cash flows, industry dominance, and compelling valuation present a strong case for a rerating, as global travel demand outpaces constrained aircraft supply.
An analysis of the bullish investment case for DaVita Inc. highlights its entrenched market position and cash flow discipline, while underscoring the significant regulatory and leverage risks inherent in the kidney care sector.
As Lifeway Foods posts steady growth, a bitter, years-long family conflict over control of the company raises red flags for investors, highlighting the risks inherent in tightly held family businesses.
A series of fabricated images purporting to show New York City Mayor Zohran Mamdani and his mother with Jeffrey Epstein and other prominent figures spread across social media this week, highlighting the escalating challenge of AI-driven political disinformation.
Despite a stellar share price run, MasTec's earnings quality is under scrutiny as persistent margin pressures from supply chain strains and strategic growth investments challenge its financial resilience. Investors are watching to see if management can steer the infrastructure giant toward more sustainable profitability.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
Analysts are building a case for Atlassian's long-term growth, citing its accelerating cloud migration, rapid AI adoption, and central role in enterprise workflow orchestration as key drivers, even as revenue recognition shifts create near-term volatility.
As the U.S. grapples with surging energy demands from AI and data centers, a new wave of companies is emerging. We look at three speculative but promising energy stocks where a modest investment could tap into long-term structural shifts.
Despite a dominant position in analytical instruments, Waters Corporation faces headwinds from a slowing Chinese market and elevated debt. We examine the investment thesis for the life sciences tools provider, weighing its recurring revenue model against current valuation concerns.
E.l.f. Beauty reports sustained sales momentum, powered by demand for its affordable products, effectively countering cost pressures from unresolved tariffs. Investor focus sharpens on the company's ability to maintain profitability amid ongoing trade uncertainties.
The Department of Justice may challenge a federal judge's order to release a five-year-old boy and his father from immigration detention, a case that has ignited debate over the administration's aggressive enforcement tactics and the conditions inside family detention centers.
The body believed to be 17-year-old Hailey Buzbee, missing since early January, was recovered in Ohio after the suspect she met through online gaming led authorities to the location, his lawyer states.
Apple's historic Q1 earnings, fueled by unprecedented iPhone demand, sent its stock on a wild ride. While the results dazzled Wall Street, muted guidance on memory cost pressures and questions about its AI roadmap tempered the celebration.
BioNTech appoints Kylie Jimenez as its first Chief People Officer, a strategic move aimed at building the organizational and cultural backbone for its ambitious transition into a multi-product oncology company by 2030.
A deep dive into the mounting challenges facing Unity Software Inc., from eroding developer trust and fierce competition to financial pressures, as a prominent bear thesis gains traction among investors.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
For retirees, homeownership offers stability but also carries unique financial risks. Financial experts emphasize that a dedicated, liquid cash reserve for unexpected repairs is non-negotiable for protecting a fixed income.
Liberty Global, Europe's cable and mobile giant, has signed a five-year strategic partnership with Google Cloud to integrate Gemini AI and cloud tools across its operations, aiming to enhance TV platforms, automate services, and explore new revenue streams.
With prized Burmese teak off-limits due to sanctions and old-growth stocks dwindling, the luxury yacht industry is accelerating its search for viable—and sustainable—alternatives, from engineered woods to advanced synthetics.
